Brokerages Set Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Price Target at $11.00
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has received an average recommendation of “Buy” from the seven research firms that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1-year price target […]
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has received an average recommendation of “Buy” from the seven research firms that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1-year price target […]
